(Q46564730)

23 December 2017

title

High-density lipoprotein apolipoprotein A-I kinetics in obesity (English)

1 reference

23 December 2017

0 references

2

Gerald F Watts

1 reference

23 December 2017

Esther MM. Ooi

1

object named as

Esther M M Ooi

1 reference

23 December 2017

author name string

Maryam S Farvid

3

1 reference

23 December 2017

Dick C Chan

4

1 reference

23 December 2017

Michael C Allen

5

1 reference

23 December 2017

Simon R Zilko

6

1 reference

23 December 2017

P Hugh R Barrett

7

1 reference

23 December 2017

publication date

1 June 2005

1 reference

23 December 2017

published in

Obesity

1 reference

23 December 2017

volume

13

1 reference

23 December 2017

page(s)

1008-1016

1 reference

23 December 2017

issue

6

1 reference

23 December 2017

Hypertriglyceridemia, insulin resistance, and the metabolic syndrome

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Dyslipidemia of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Value of HDL cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I/A-II in prediction of coronary heart disease: the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Enhanced fractional catabolic rate of apo A-I and apo A-II in heterozygous subjects for apo A-I(Zaragoza) (L144R).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Effects of atorvastatin versus fenofibrate on apoB-100 and apoA-I kinetics in mixed hyperlipidemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans: in vivo evidence for a link between HDL apoC-III and apoA-I metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Effect of dietary omega-3 fatty acids on high-density lipoprotein apolipoprotein AI kinetics in type II diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Apolipoprotein A-I and A-II kinetic parameters as assessed by endogenous labeling with [(2)H(3)]leucine in middle-aged and elderly men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Lipoprotein metabolism in obesity and diabetes: insights from stable isotope kinetic studies in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Clinical significance of high-density lipoproteins and the development of atherosclerosis: focus on the role of the adenosine triphosphate-binding cassette protein A1 transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Apolipoprotein B/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Dyslipidemia in visceral obesity: mechanisms, implications, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

HDL metabolism in hypertriglyceridemic states: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Apolipoprotein A-I, B-100, and B-48 metabolism in subjects with chronic kidney disease, obesity, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Dietary fat increases high density lipoprotein (HDL) levels both by increasing the transport rates and decreasing the fractional catabolic rates of HDL cholesterol ester and apolipoprotein (Apo) A-I. Presentation of a new animal model and mechanisti

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Effects of glucose and insulin on rat apolipoprotein A-I gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Insulin induction of apolipoprotein AI, role of Sp1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Glucose regulates the transcription of human genes relevant to HDL metabolism: responsive elements for peroxisome proliferator-activated receptor are involved in the regulation of phospholipid transfer protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

The apoAI-CIII-AIV gene cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Multiple Rare Alleles Contribute to Low Plasma Levels of HDL Cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Genetic and environmental determinants of plasma high density lipoprotein cholesterol and apolipoprotein AI concentrations in healthy middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Human intestinal lipoproteins. Studies in chyluric subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Effects of micronized fenofibrate on insulin resistance in patients with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distri

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

High-density lipoprotein apolipoprotein A-I kinetics in obese insulin resistant patients. An in vivo stable isotope study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Familial HDL deficiency characterized by hypercatabolism of mature apoA-I but not proapoA-I

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Increased production of HDL ApoA-I in homozygous familial defective ApoB-100

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Subjects with ApoA-I(Lys107-->0) exhibit enhanced fractional catabolic rate of ApoA-I in Lp(AI) and ApoA-II in Lp(AI with AII)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

Dietary fat elevates hepatic apoA-I production by increasing the fraction of apolipoprotein A-I mRNA in the translating pool

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2005.118

31 March 2020

Identifiers

DOI

10.1038/OBY.2005.118

1 reference

23 December 2017

PubMed ID

15976143

1 reference

23 December 2017